Patents by Inventor Alexander Steck

Alexander Steck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260191436
    Abstract: A non-invasive analyte sensor with at least two electrodes, each having a skin contacting surface. At least one of the electrodes is a detection electrode. The detection electrode includes at least one analyte-responsive layer and at least one conversion layer. At least one other of the electrodes is configured as an auxiliary electrode configured as either a counter, or a combined counter-reference electrode.
    Type: Application
    Filed: March 5, 2026
    Publication date: July 9, 2026
    Inventors: Alexander Steck, Kirill Sliozberg
  • Patent number: 12607591
    Abstract: This disclosure generally relates to a flux-limiting polymer membrane for an analyte sensor and to an analyte sensor having a flux-limiting polymer membrane.
    Type: Grant
    Filed: May 19, 2023
    Date of Patent: April 21, 2026
    Assignee: Roche Diabetes Care, inc.
    Inventor: Alexander Steck
  • Publication number: 20260102083
    Abstract: A medical system and a method for monitoring the storage conditions of at least one medical system are disclosed. The medical system includes at least one analyte sensor for detecting at least one analyte in a bodily fluid, the analyte sensor being configured for at least partial transcutaneous insertion into a body tissue of a user; and at least one disabling device operably connected to the analyte sensor. The disabling device includes at least one monitoring element wherein the monitoring element is configured for undergoing a change in at least one mechanical property when storage conditions of the analyte sensor are outside a specification range. The mechanical property change is configured such that the transcutaneous insertion of the analyte sensor into the body tissue is irreversibly prevented.
    Type: Application
    Filed: December 17, 2025
    Publication date: April 16, 2026
    Inventors: Alexander Steck, Kirill Sliozberg
  • Patent number: 12599322
    Abstract: This disclosure relates to a process for forming a membrane on an analyte sensor and further relates to an analyte sensor obtainable by this process. This disclosure also relates to a process for forming a sensing layer on an electrode of an analyte sensor and to an analyte sensor having the sensing layer obtainable by the inventive process as well as the membrane obtainable by the inventive process. The analyte sensors obtainable by the inventive processes may be used for conducting an analyte measurement of a body fluid of a user or a patient. This disclosure may be applied in the field of home care as well as in the field of professional care, such as in hospitals. Other applications are generally feasible.
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: April 14, 2026
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Peng Zou, Alexander Steck, Gernot Hochmuth, Reinhold Mischler, Kirill Sliozberg, Christian Hoertz
  • Patent number: 12588836
    Abstract: A method of preparing a working electrode on a sensor substrate is disclosed. A sensor substrate is provided and has a first side with at least one conductive trace. A layer of sensing material is applied onto the first side and covers at least a portion of the at least one conductive trace. The sensing material is irradiated with a laser beam to partially remove the layer of the sensing material while preserving a portion of the sensing material covering the at least one conductive trace, resulting in a working electrode on the sensor substrate. A membrane layer is applied that at least partially covers the working electrode. The membrane layer includes a cross-linker that cross-links at least a part of the sensing material. A diffusion step is performed during which the cross-linker in the membrane layer at least partially diffuses into the sensing material.
    Type: Grant
    Filed: September 12, 2022
    Date of Patent: March 31, 2026
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Gernot Hochmuth, Kirill Sliozberg, Alexander Steck
  • Publication number: 20260069172
    Abstract: The present disclosure relates to an electrode system for measuring the concentration of an analyte under in-vivo conditions, comprising an electrode with immobilized enzyme molecules and a diffusion barrier that controls diffusion of the analyte from body fluid surrounding the electrode system to the enzyme molecules.
    Type: Application
    Filed: September 25, 2025
    Publication date: March 12, 2026
    Inventors: Gregor Ocvirk, Angelika Fuerst, Alexander Steck, Juergen Woehrle
  • Patent number: 12507924
    Abstract: A fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid has a substrate with a first surface configured to face towards the body fluid. The sensor has a working electrode and an interferent electrode. The interferent electrode and the working electrode are electrically separated layers located adjacently on the first surface. The sensor has a further electrode, the further electrode being a counter electrode, a reference electrode or a counter/reference electrode. The working electrode and the interferent electrode each have a layer of a conductive material. The working electrode has an enzyme whereas the interferent electrode is devoid of enzyme. A method for producing the fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid is also disclosed.
    Type: Grant
    Filed: February 22, 2023
    Date of Patent: December 30, 2025
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Gernot Hochmuth, Kirill Sliozberg, Alexander Steck
  • Patent number: 12507923
    Abstract: A fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid has a substrate with a first surface configured to face towards the body fluid. The sensor has a working electrode and an interferent electrode. The interferent electrode and the working electrode are electrically separated layers located adjacently on the first surface. The sensor has a further electrode, the further electrode being a counter electrode, a reference electrode or a counter/reference electrode. The working electrode and the interferent electrode each have a layer of a conductive material. The working electrode has an enzyme whereas the interferent electrode is devoid of enzyme. A method for producing the fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid is also disclosed.
    Type: Grant
    Filed: September 21, 2022
    Date of Patent: December 30, 2025
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Gernot Hochmuth, Kirill Sliozberg, Alexander Steck
  • Patent number: 12498342
    Abstract: The present invention relates to a method for the preparation of a working electrode, the method comprising application of a sensing material in several steps. Further, the present invention relates to an analyte sensor comprising the working electrode as well as to the use of the analyte sensor for detecting at least one analyte in a sample.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: December 16, 2025
    Inventors: Arnfried Guenther, Alexander Steck
  • Patent number: 12450901
    Abstract: Systems and methods for measuring an analyte include devices configured to perform an analyte testing operation. The devices include a wearable electronic device and a remote device operatively connected to each other and each having a processor, the processors cooperating with each other in the execution of program instructions to measure an analyte. The wearable electronic device includes a camera configured to generate a video stream, which is analyzed to identify missing test components, to identify the application of a body fluid on a test strip where the sample undergoes changes in one or more optical properties, the image of which is analyzed to determine a level of the analyte. The wearable electronic device further includes a head-up display (HUD) for providing output messages to the user relating to the performance and status of the analyte testing operation.
    Type: Grant
    Filed: April 19, 2024
    Date of Patent: October 21, 2025
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Alexander Steck, Bernhard Limburg, Fredrik Hailer, Max Berg
  • Patent number: 12446802
    Abstract: The present disclosure relates to an electrode system for measuring the concentration of an analyte under in-vivo conditions, comprising an electrode with immobilized enzyme molecules and a diffusion barrier that controls diffusion of the analyte from body fluid surrounding the electrode system to the enzyme molecules.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: October 21, 2025
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Gregor Ocvirk, Angelika Fuerst, Alexander Steck, Juergen Woehrle
  • Patent number: 12360073
    Abstract: A method for determining a membrane property of an analyte sensor that has at least two measurement electrodes and at least one of the measurement electrodes has a membrane having the membrane property. The method includes generating a fast-transient voltage signal and applying the fast-transient voltage signal to the measurement electrodes. A response signal is measured, and the membrane property is determined by evaluating the response signal.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: July 15, 2025
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Michael Lambertson, Kirill Sliozberg, Alexander Steck, Frederic Wehowski
  • Publication number: 20240324918
    Abstract: The disclosure relates to an analyte sensor comprising a substrate, at least one working electrode, at least one second electrode and a membrane, wherein the membrane is located on top of the second electrode, and the second electrode has at least one first silver layer and at least one second silver layer which partially overlap with one another and have the same composition. The first and second silver layers intersect with one another to form a + or a T shape design. The sensor includes at least one exposed area of the first silver layer disposed on the exterior of the sensor to provide for direct contact with body fluid when implanted. The disclosure further relates to a process for manufacturing an analyte sensor.
    Type: Application
    Filed: June 12, 2024
    Publication date: October 3, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Kirill Sliozberg, Alexander Steck
  • Publication number: 20240260863
    Abstract: Systems and methods for measuring an analyte include devices configured to perform an analyte testing operation. The devices include a wearable electronic device and a remote device operatively connected to each other and each having a processor, the processors cooperating with each other in the execution of program instructions configured to direct the devices in the performance of the analyte testing operation. The wearable electronic device includes a camera configured to generate a video stream and one or more images relating to a user removing a test strip from a vial, producing a bodily fluid sample, and applying the sample to a deposit site of the test strip where the sample undergoes changes in one or more optical properties, the image of which is analyzed to determine a level of the analyte. The wearable electronic device further includes a head-up display (HUD) for providing output messages to the user relating to the performance and status of the analyte testing operation.
    Type: Application
    Filed: April 18, 2024
    Publication date: August 8, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Max Berg, Fredrik Hailer, Bernd Limburg, Alexander Steck
  • Publication number: 20240265699
    Abstract: Systems and methods for measuring an analyte include devices configured to perform an analyte testing operation. The devices include a wearable electronic device and a remote device operatively connected to each other and each having a processor, the processors cooperating with each other in the execution of program instructions to measure an analyte. The wearable electronic device includes a camera configured to generate a video stream, which is analyzed to identify missing test components, to identify the application of a body fluid on a test strip where the sample undergoes changes in one or more optical properties, the image of which is analyzed to determine a level of the analyte. The wearable electronic device further includes a head-up display (HUD) for providing output messages to the user relating to the performance and status of the analyte testing operation.
    Type: Application
    Filed: April 19, 2024
    Publication date: August 8, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Alexander Steck, Bernhard Limburg, Fredrik Hailer, Max Berg
  • Publication number: 20240252070
    Abstract: A method for measuring an analyte includes identifying a test strip in a video stream generated by a camera based on at least one registration mark associated with the test strip depicted in the video stream, identifying application of a fluid dose to a deposit site formed on the test strip based on the video stream, activating a timer in response to the identification of the application of the fluid dose, generating at least one optical measurement of a reagent located at a measurement site on the test strip, and generating a measurement of an analyte in the fluid dose based on the at least one optical measurement of the reagent only in response to the at least one optical measurement being generated after a predetermined minimum time period has elapsed and prior to a predetermined maximum time period elapsing subsequent to the activating of the timer.
    Type: Application
    Filed: April 10, 2024
    Publication date: August 1, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Alexander Steck, Max Berg, Fredrik Hailer, Bernd Limburg
  • Publication number: 20240201123
    Abstract: The present invention relates to an analyte sensor comprising a substrate, at least one first electrode, at least one second electrode and at least one protective layer covering the at least one second electrode. The present invention further relates to a process for manufacturing the inventive analyte sensor as well as to an analyte sensor system comprising an analyte sensor according to the present invention and an electronics unit. The analyte sensor according to the present invention may mainly be used for conducting analyte measurements in a body fluid of a user.
    Type: Application
    Filed: February 26, 2024
    Publication date: June 20, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Alexander Steck
  • Publication number: 20240148292
    Abstract: The present invention relates to an analyte sensor comprising a substrate, at least one first electrode, at least one second electrode and at least one protective layer covering the at least one second electrode. The present invention further relates to a process for manufacturing the inventive analyte sensor as well as to an analyte sensor system comprising an analyte sensor according to the present invention and an electronics unit. The analyte sensor according to the present invention may mainly be used for conducting analyte measurements in a body fluid of a user.
    Type: Application
    Filed: January 18, 2024
    Publication date: May 9, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Kirill Sliozberg, Alexander Steck
  • Publication number: 20240122509
    Abstract: The disclosure relates to an analyte sensor comprising a substrate, at least one working electrode, at least one second electrode and a membrane, wherein the membrane is located on top of the second electrode, and the second electrode has at least one first silver layer and at least one second silver layer which at least partially overlap with one another and have different compositions. The sensor includes at least one exposed area of the first silver layer disposed on the exterior of the sensor to provide for direct contact with body fluid when implanted. The disclosure further relates to a process for manufacturing an analyte sensor.
    Type: Application
    Filed: December 19, 2023
    Publication date: April 18, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Kirill Sliozberg, Alexander Steck
  • Publication number: 20240060927
    Abstract: An analyte sensor for determining at least one analyte and a method for producing an analyte sensor are disclosed. The analyte sensor has a substrate. A working electrode and a conductive layer are located on different sites on the substrate. A layer having silver and/or a silver compound partially covers the conductive layer. A protective layer covers (i) the layer having silver, and also covers (ii) a portion of the conductive layer. The disclosed analyte sensor significantly reduces noise during measurements. The method can be performed in an easier manner compared to producing prior art analyte sensors and allows considerably higher tolerances during production.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 22, 2024
    Inventors: Kirill Sliozberg, Alexander Steck